Complement downregulation promotes an inflammatory signature that renders colorectal cancer susceptible to immunotherapy. (2022)

First Author: Krieg C
Attributed to:  Targeting the complement system to improve radiation response funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/jitc-2022-004717

PubMed Identifier: 36137652

Publication URI: http://europepmc.org/abstract/MED/36137652

Type: Journal Article/Review

Volume: 10

Parent Publication: Journal for immunotherapy of cancer

Issue: 9

ISSN: 2051-1426